PT102642B - Composicao farmaceutica de dosagem unica diaria contendo brivudine - Google Patents
Composicao farmaceutica de dosagem unica diaria contendo brivudineInfo
- Publication number
- PT102642B PT102642B PT102642A PT10264201A PT102642B PT 102642 B PT102642 B PT 102642B PT 102642 A PT102642 A PT 102642A PT 10264201 A PT10264201 A PT 10264201A PT 102642 B PT102642 B PT 102642B
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical
- dosage containing
- pharmaceutical composition
- unique dosage
- containing brivudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000009A ITMI20010009A1 (it) | 2001-01-03 | 2001-01-03 | Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera |
Publications (2)
Publication Number | Publication Date |
---|---|
PT102642A PT102642A (pt) | 2002-07-31 |
PT102642B true PT102642B (pt) | 2003-06-30 |
Family
ID=11446384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT102642A PT102642B (pt) | 2001-01-03 | 2001-07-05 | Composicao farmaceutica de dosagem unica diaria contendo brivudine |
Country Status (20)
Country | Link |
---|---|
AT (1) | AT6141U1 (sk) |
BE (1) | BE1014522A5 (sk) |
CH (1) | CH695662A5 (sk) |
CZ (1) | CZ20012464A3 (sk) |
DK (1) | DK177084B1 (sk) |
ES (1) | ES2192456B1 (sk) |
FI (1) | FI20011446A (sk) |
FR (1) | FR2818907B1 (sk) |
GB (1) | GB2370771A (sk) |
GR (1) | GR1004012B (sk) |
HR (1) | HRPK20010345B3 (sk) |
HU (1) | HUP0102816A3 (sk) |
IE (1) | IE20010413A1 (sk) |
IT (1) | ITMI20010009A1 (sk) |
NL (1) | NL1018431C2 (sk) |
PL (1) | PL348480A1 (sk) |
PT (1) | PT102642B (sk) |
SE (1) | SE0102309L (sk) |
SK (1) | SK287043B6 (sk) |
UA (1) | UA76402C2 (sk) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239527B1 (es) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | Composicion farmacologica de uso topico para el tratamiento del herpes zoster. |
CN113712928A (zh) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | 经口腔粘膜吸收的溴夫定药物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0104857A1 (en) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Deoxyuridine compounds, methods for preparing them and their use in medicine |
IT1170232B (it) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | Composizioni terapeutiche ad attivita' antivirale |
US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
DK0874631T3 (da) * | 1996-01-19 | 2004-03-22 | Glaxo Group Ltd | Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/it unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/xx not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/de not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/ not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/fr not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/da not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/nl not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/fi not_active Application Discontinuation
- 2001-07-04 SK SK957-2001A patent/SK287043B6/sk not_active IP Right Cessation
- 2001-07-04 UA UA2001074658A patent/UA76402C2/uk unknown
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/cs unknown
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/fr not_active IP Right Cessation
- 2001-07-05 PL PL01348480A patent/PL348480A1/xx not_active Application Discontinuation
- 2001-07-05 PT PT102642A patent/PT102642B/pt active IP Right Grant
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/hu unknown
- 2001-07-05 GR GR20010100322A patent/GR1004012B/el unknown
- 2001-07-05 ES ES200101566A patent/ES2192456B1/es not_active Expired - Fee Related
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI20011446A (fi) | 2002-07-04 |
UA76402C2 (en) | 2006-08-15 |
SE0102309L (sv) | 2002-07-04 |
HUP0102816A2 (en) | 2002-10-28 |
BE1014522A5 (fr) | 2003-12-02 |
ITMI20010009A0 (it) | 2001-01-03 |
DK177084B1 (da) | 2011-07-11 |
SE0102309D0 (sv) | 2001-06-28 |
CH695662A5 (de) | 2006-07-31 |
AT6141U1 (de) | 2003-05-26 |
NL1018431C2 (nl) | 2002-07-05 |
GR1004012B (el) | 2002-11-01 |
DK200101019A (da) | 2002-07-04 |
PL348480A1 (en) | 2002-07-15 |
SK287043B6 (sk) | 2009-10-07 |
GB0110682D0 (en) | 2001-06-20 |
HRPK20010345B3 (en) | 2005-02-28 |
GB2370771A (en) | 2002-07-10 |
ES2192456A1 (es) | 2003-10-01 |
FR2818907B1 (fr) | 2006-05-26 |
FI20011446A0 (fi) | 2001-07-03 |
FR2818907A1 (fr) | 2002-07-05 |
HU0102816D0 (en) | 2001-09-28 |
GR20010100322A (el) | 2002-10-08 |
HRP20010345A2 (en) | 2003-08-31 |
IE20010413A1 (en) | 2003-04-16 |
CZ20012464A3 (cs) | 2002-08-14 |
HUP0102816A3 (en) | 2005-01-28 |
PT102642A (pt) | 2002-07-31 |
ITMI20010009A1 (it) | 2002-07-03 |
ES2192456B1 (es) | 2005-02-01 |
SK9572001A3 (en) | 2003-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
PT1066027E (pt) | Composicao farmaceutica de topiramato | |
FI20011478A0 (fi) | Farmaseuttinen koostumus | |
IS6986A (is) | Lyfjasamsetning í vökvaformi | |
PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
HRP20030873A2 (en) | Pharmaceutical dosage form of amorphous nelfinavirmesylatoe having such element | |
PT1235799E (pt) | Forma polimorfica de atorvastatina-calcio | |
EE200200486A (et) | Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid | |
DK1674084T3 (da) | Forlænget frigivelse af oral dosissammensætning | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
PT1458377E (pt) | Composicoes farmaceuticas contendo tegaserod | |
BRPI0209720A2 (pt) | dosagem e embalagem de medicação com liberação controlada | |
EE200300589A (et) | Ravimkoostised | |
FI20022128A0 (fi) | Farmaseuttinen koostumus | |
PT1558263E (pt) | Composicao farmaceutica de libertacao prolongada | |
ATE324883T1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
NO20021898D0 (no) | Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
LU90483B1 (fr) | Compositions nouvelles de m-thanesulfonate de parox-tine | |
HUP0401862A3 (en) | Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them | |
PT102642A (pt) | Composicao farmaceutica de dosagem unica diaria contendo brivudine | |
ITBO20010005V0 (it) | Distributore automatico di medicinali | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 20030514 |